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Re-organisation of oesophago-gastric cancer
services in England and Wales: a follow-up
assessment of progress and remaining challenges
Oliver Groene1,2*, Georgina Chadwick2, Stuart Riley3, Richard H Hardwick4, Tom Crosby5, Kimberley Greenaway6,
William Allum7 and David A Cromwell1,2
Abstract
Background: This study is an update on an earlier article in 2007 to assess the implementation of the Cancer Plan
reform strategy in England and Wales.
Findings: A national online survey to upper gastro-intestinal leads at network and trust level. The questionnaire
was designed based on existing clinical practice guidelines and addressed governing principles and operational
procedures related to the delivery of cancer care. It was sent in January 2012 to upper gastro-intestinal network
and trusts leads at all cancer networks and acute NHS organisations in England and Wales. Responses were received
from 100% of Cancer Networks and 91% of NHS organisations. Centralisation of surgery has improved with all but
two trusts (5.4%) now meeting the minimum staffing level for oesophago-gastric cancer surgery. This is a substantial
improvement since the 2007 survey when 21 trusts (46.7%) did not meet this requirement. The use of formal
assessment for nutritional needs has improved, too. In 2007, the involvement of the palliative care team in
multi-disciplinary teams was poor. While this has improved, 27 trusts (19.7%) still report that none of the palliative
care team members routinely attend the multi-disciplinary team discussion.
Conclusions: The survey demonstrates improved compliance with organisational recommendations since the last
assessment in 2007. Centralisation of surgery has improved and is nearly fully compliant with the reform strategy.
Areas that require further improvement are nutritional support and inclusion of palliative care in multi-disciplinary
team meetings.
Findings
This study is an update on an earlier assessment of the
implementation of Cancer Networks for patients diag-
nosed with oesophago-gastric (O-G) cancer [1]. Cancer
Networks were established a decade ago in England and
Wales following the Cancer Plan reform strategy with the
aim to integrate service provision and improve outcomes
[2,3]. Patients diagnosed with oesophageal-gastric cancer
(and high-grade dysplasia (HGD), a pre-cancerous alter-
ation of the cells of the oesophagus) require a range of
diagnostic, therapeutic and palliative services. The Cancer
Plan stipulates that each network should contain one or
more specialist cancer centres that provide curative sur-
gical treatment and specialist radiology, oncology and
palliative services to all patients living in the area. Diag-
nostic services and most palliative services continue to
be provided by individual NHS organisations (local units)
within the network areas. Once a diagnosis is made, all
HGD and O-G cancer patients should be discussed in a
specialist multi-disciplinary team meeting (MDT) to
decide appropriate treatment options. Treatment could
include curative surgery (with options for adjuvant/
neoadjuvant chemo/radiotherapy) as well as other treat-
ments, which include chemotherapy and or radiotherapy
and endoscopic therapies such as stenting, laser ablation,
endoscopic mucosal resection and others. Such options
should be supported by specialist palliative care teams,
and nutritionists. To ensure access to appropriate staging
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investigations, diagnosis, treatment and palliative care of
O-G patients, a clear system of coordination between
local units and specialist centres within a network is re-
quired (Figure 1).
Methods
In 2007, an organisational survey of English O-G cancer
networks and trust assessed the extent to which the exten-
sive re-organisation of oesophago-gastric cancer services
had been completed, and whether the provision of diag-
nostic, therapeutic and support services was variable across
networks and trusts [1]. The survey highlighted that the
process of re-organisation was incomplete, in particular
with regard to the centralisation of surgery. Moreover, it
pointed out that patients were not sufficiently discussed at
the specialist MDTs and that access to endoscopic ther-
apies was variable across networks. In addition, dietician
support and nutritional assessment of patients and
involvement of palliative care teams in the specialist
MDTs was insufficient. Recent surveys on the manage-
ment of Barrett’s Oesophagus, too, highlighted variations
in comparison with guidelines and consensus statements
[4,5]. Therefore, we conducted a follow-up organisational
survey of O-G cancer networks and trusts in order to
assess whether variations in management persist and
whether progress has been made in the re-organisation
and provision of services for O-G cancer in England and
Wales since 2007.
Data on the organisation O-G cancer was collected
using two separate questionnaires (Additional files 1, 2).
The first focused on organisation of services within cancer
networks assessing governing principles that inform
clinicians, define the scope of care, guide decision-making,
and ensure consistency in implementation. Areas of
assessment included are referral criteria, organisation
of the specialist MDT, access to medical oncology and
endoscopic palliative services. The second question-
naire addressed characteristics of services available in
individual NHS trusts, focusing on access to specific
treatments and relevant professionals.
Questionnaire items were derived from guidelines on
management of patients with oesophago-gastric cancer
[6-11]. Where possible, we included questions from the
previous organisational survey to enable direct compari-
sons and change of time regarding compliance with rec-
ommended standards of care. Additional questions were
added to the survey to assess the management of pa-
tients with oesophageal high-grade glandular dysplasia
(HGD), a precancerous lesion that might developed into
oesophageal cancer, as previous studies suggest variabil-
ity in management and treatment.
A list of networks and all NHS acute trusts involved
in the treatment of HGD and oesophago-gastric cancer
was prepared from sources at the Health and Social Care
Information Centre. Links to the online questionnaires
were sent to the Cancer Network O-G cancer lead clin-
ician for the network survey and to trust/unit O-G cancer
leads for the NHS trust survey. These links were adminis-
tered in February 2012 and non-responders were followed
up by email and telephone until April 2012. This study
was conducted as part of the National Oesophago-Gastric
Cancer Audit which has ethical approval and Section 251
approval granted by the Information Governance Board
of The Health and Social Care Information Centre
(ECC Reference Number: ECC 1–06 © /2011 National
Oesophago-gastric cancer audit).
In 2007, 30 Cancer Networks existed, but three Cancer
Networks (Leicestershire, Northamptonshire and Rutland,
Derby/Burton and Mid Trent) were combined in 2008 to
form East Midlands Cancer Network. 154 trusts provided
oesophago-gastric cancer services, with 44 trusts being
designated specialist centres. In 2012, 28 Cancer Networks
existed in England and 151 trusts provided O-G cancer
services, of which 39 trusts were designated specialist cen-
tres. In Wales, 2 Cancer Networks and 2 specialist trusts
existed.
We report the results as the proportion of responding
networks and trusts. Where appropriate, differences be-
tween specialist and local units were assessed using the
Chi-squared test. All p-values are two-sided and those
lower than 0.05 were considered to indicate a statistically
significant result. STATA 11 was used for all statistical
calculations.
Results
Questionnaires were returned from all Cancer Networks
in England (N = 28) and Wales (N = 2). For the NHS trust
survey, questionnaires were received from 137 of 151
trusts (90.7%). Completeness of the surveys was very high.
Where we report on denominators lower than 30 and 137,
respectively, this is mostly due to a) non-applicability of
an item or b) 2007 vs 2012 comparisons, where different
number of networks and trusts were in place.
Network level referral criteria and management policy
Of the Cancer Networks, 23 (76.7%) had a specialist sur-
veillance policy for patients with Barrett’s oesophagus,
and 26 of the 30 networks (86.7%) had a policy for the
management of HGD. In accordance with current guide-
lines and line with measures of the National Cancer Peer
Review Programme, all but one network (96.7%) re-
ported that referral criteria for O-G cancer patients were
documented and had a policy to ensure that all
oesophageal-gastric cancer patients are referred to and
discussed at MDT meetings. In addition, 90% of the net-
works reported that the policy covered patients with
high grade dysplasia as well.
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Figure 1 The Cancer Networks in England and Wales that existed on 1 April 2011.
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Implementation of the MDT policy at trust level
All trusts now run MDTs to plan the management of
patients and since the last survey a substantially higher
number of local units are having combined MDTs with
their specialist centres, 63 (70.8%) vs 44 (50.0%) in 2007.
Virtually all patients in need of specialist input or eli-
gible for curative resection are now routinely referred to
the specialist MDT; however, only 84 trusts (61.3%)
referred patients on a best-supportive care pathway. 80
trusts (58.4%) reported discussing all oesophago-gastric
cancer patients at the MDT (82.1% at specialist centres
vs. 49.0% at local units). Furthermore, 11 (8.0%) trusts
do not list private patients at all, and a further 10 (7.3%)
reported that private patients were not formally listed.
Generally specialist centres were more likely to include
private patients in MDT discussions than local units (p =
0.017).
Organisation and management of patients with High
Grade Dysplasia
105 (76.6%) trusts reported that the diagnosis of HGD was
confirmed by at least two pathologists with gastrointes-
tinal interest; in line with clinical practice guidelines [8,9].
Of the remaining trusts, 24 (17.6%) reported that diagno-
sis was confirmed by a pathologist with gastrointestinal
interest and 5 (3.6%) stated the diagnosis was based on
confirmation by a general pathologist. Responses from 3
trusts (2.2%) were missing. Specialist centres reported a
slightly higher compliance of diagnosis in line with clinical
practice guidelines, although the difference did not reach
statistical significance (p = 0.101).
At present, trusts vary in their mechanisms to ensure
referral of HGD patients to an MDT. The most common
mechanisms were: referral by clinician (n = 30, 21.9%) or
referral by combination of clinician, pathologist and
endoscopist (n = 22, 16.1%), referral by combination of
clinician and pathologist (n = 16, 11.7%). However, 11
(8.0%) trusts reported having no specific mechanism.
The remainder of trusts used other combinations of
clinician, pathologist and/or endoscopist referral.
Various endoscopic and surgical options are available for
the treatment of HGD and it is recommended that trusts
have access to oesophagectomy, endoscopic mucosal resec-
tion and at least one of the thermal ablation therapies
(argon beam coagulation, multipolar electrocautery, laser
therapy, cryotherapy, radiofrequency ablation). The major-
ity of trusts (n = 132, 96.4%) fulfil this recommendation,
although there is considerable variability between trusts
with regards to the options available to them (Table 1).
Access to curative surgical services in specialist centres
Currently 39 specialist cancer centres provide surgery
for oesophageal and gastric resections, responses to the
organisational survey were returned by 37 of these. In
order to ensure adequate specialist cover 7 days a week
including out of hours to manage postoperative compli-
cations, the National Cancer Manual recommends that
these surgical teams comprise at least three specialist
consultant surgeons to manage surgery and postopera-
tive care, although the ideal number would be 4–6 [11].
Only two trusts (5.4%) did not meeting the minimum
requirement of having at least three surgeons (Table 2).
This is a substantial improvement on the 2007 survey
when only 53.3% of centres had three surgeons or more.
Access to nutritional support at trust level
Oesophago-gastric cancer patients should have access
to dietician advice if needed and should be assessed for
nutritional risk using a validated screening tool [8].
Compared to 2007, dietician access has improved for
surgical patients in specialist centres. Likewise, nutri-
tional assessment improved with trusts more likely to
conduct nutritional assessment and utilise formal
screening instruments (Table 3).
Access to oncology care and endoscopy procedures in
Cancer Networks
As the choice of endoscopic and radiological palliative ther-
apies to treat obstructive oesophageal symptoms depends
Table 1 Therapeutic procedures available for patients
with high grade dysplasia
n = 137 Available at local trust or access
at other hospital in network
Procedure No Yes
Oesophagectomy 3 (2.2%) 134 (97.8%)
Endoscopic Mucosal Resection 4 (2.9%) 133 (97.1%)
Argon plasma coagulation 21 (15.3%) 116 (84.7%)
Radiofrequency ablation 26 (19.0%) 111 (81.0%)
Photodynamic therapy 37 (27.0%) 100 (73.0%)
Laser therapy 62 (45.3%) 75 (54.7%)
Multipolar electrocautery 81 (59.1%) 56 (40.9%)
Cryotherapy 98 (71.5%) 39 (28.5%)
Table 2 Distribution of surgeons performing oesophago-
gastric curative surgery among the specialist O-G cancer
centres
Number of employed or visiting
surgeons at the trust
2007 (n = 45) 2012 (n = 37)
2 21 (46.7%) 2 (5.4%)
3 14 (31.1%) 13 (35.1%)
4 3 (6.6%) 8 (21.6%)
5 7 (15.6%) 7 (18.9%)
6 0 5 (13.5%)
7+ 0 2 (5.4%)
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on individual patient characteristics, availability of a range
of treatments is recommended [8]. All Cancer Networks
provided access to stent insertion and the majority (85.7%)
provided access to argon beam coagulation (Table 4).
Brachytherapy and laser ablation could be performed in
only about half of the Cancer Networks and is typically per-
formed in specialist centres. Only eight specialist centres
(28.6%) offered access to photodynamic therapy, and none
of the local units did. Local units in general provided less
access to these endoscopic procedures.
Eight networks (36.4%) reported that patients had dif-
ficulties in accessing oncological therapy within two
weeks of the decision to treat. These difficulties applied
to both patients receiving both curative and palliative
treatment, and did not differ between specialist centres
and local units. This is in contrast to 2007, where six
networks reported difficulties in accessing oncological
radiotherapy, mostly related to access to radiotherapy
among specialist centres.
Provision of palliative care at trust level
In 2007, the involvement of the palliative care team in
the MDT was poor, with none of its team members rou-
tinely attending the MDT in 10 (26.3%) cancer centres
and 26 (29.5%) of local trusts. In 2012, 56 trusts (40.9%)
reported that only the specialist nurse attends the MDT
while 23 (16.8%) trusts reported that both the consultant
and specialist nurse attended the MDT. In addition, 27
trusts (19.7%) stated that none of the palliative care team
members routinely attend the MDT meeting. All units
now provide access to a palliative care team for patients
with oesophago-gastric cancer. All but 4 trusts (2.9%)
have implemented an approach to end of life care, with
most (n = 129, 94.1%) following the Liverpool Care
Pathway.
Comparing the 2007 and 2012 data
Comparing the data from this survey to the previous
survey in 2007 allows assessing how the organisation of
services is changing over time. Our analysis suggests that
overall policies and operational principles are improving
in line with the initial reform plan and recommended
standards of care.
The structures and procedures for patients with high-
grade glandular oesophageal dysplasia reveal that three
quarters of trusts had an agreed policy for management
of patients with HGD and followed the recommendation
to base diagnosis on confirmation by at least two pathol-
ogists with a gastro-intestinal interest [6]. Access to both
endocopic and surgical treatment for HGD were gener-
ally very good. However, methods of referral to the
MDT were variable once the diagnosis was made.
For patients with oesophago-gastric cancer, access to
appropriate staging investigations, inclusion in specialist
MDTs for curative patients and access to curative ser-
vices appear good and with little variability across net-
works. Likewise, dietician support for surgical patients
has increased since 2007 even though the use of stan-
dardized tools for nutritional assessment is still low.
Nevertheless, the proportion of NHS organisations that
formally assess nutritional status before treatment has
increased significantly.
It appears that less progress has been made in involving
palliative care consultants in the care of incurable patients
at MDT meetings. This is likely to be due to the national
Table 3 Dietician access and nutritional assessment in specialist centres and local units*
2007 2012
Specialist centres n (%) Local units n (%) Specialist centres n (%) Local units n (%)
Dietician access
Surgical patients 28 (73.7) NA 33 (84.6) NA
All other O-G patients 34 (89.5) 75 (85.2) 29 (74.4) 84 (85.7)
Outpatients 32 (84.2) 72 (81.8) 29 (74.4) 74 (75.5)
Nutritional assessment
No formal assessment 9 (23.7) 32 (36.4) 3 (7.7) 15 (15.3)
Dietician assessment 26 (68.4) 43 (48.9) 26 (66.7) 63 (64.3)
Formal screening instrument 3 (7.9) 13 (14.8) 16 (41.0) 38 (38.8)
*2007 results based on 38 centres and 88 local units; 2012 results based on 39 centres and 98 local units.
Table 4 Access to endoscopic procedures in cancer
Networks
n = 28 Access to endoscopic procedures in the
Cancer Network (either at specialist or
local centre)
Procedure No Yes
Endoscopic stent insertion 0 28 (100%)
Laser ablation 13 (46.4%) 15 (53.6%)
Photodynamic therapy 20 (71.4%) 8 (28.6%)
Argon beam coagulation 4 (14.3%) 24 (85.7%)
Brachytherapy 13 (46.4%) 15 (53.6%)
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shortage of such clinicians and the practical challenges of
them attending multiple weekly MDTs. A fifth of trusts
still have no representative from the palliative care team at
MDTs. While overall access to palliative endoscopic ther-
apies is good, brachytherapy is poorly available and rarely
used. Only 50% of networks have access to this palliative
modality and even where it is available it is rarely used.
The reasons for this are unclear as brachytherapy is asso-
ciated with fewer side effects and better palliation than
endoluminal stents in patients expected to survive more
than three months [12]. Concerning end of life care,
the majority of trusts report the implementation of the
Liverpool Care Pathway to manage patients in the last
days of their life. Further attention should focus on the
appropriate planning of palliative community services
to reduce admission rates near end of life [13-15].
Since the time of initiating the reorganisation of can-
cer services, survival of patients undergoing curative sur-
gery has improved from 34% for oesophageal tumours
and 40% for gastric tumours to 45% and 50%, respect-
ively [16,17]. Whilst these improvements can not dir-
ectly be related to the reorganization of services, it is
plausible that the concentration of curative surgery
brought about improvements in survival in this group of
patients. The need for centralisation of cancer services
and in particular for cancer surgery has been highlighted
by multiple studies showing reduced complications and
improved short-term mortality if surgery is performed in
a high volume unit [18-20]. Such studies have led to rec-
ommendation of minimum volume standards for indi-
vidual surgeons.
The results of the survey confirm and complement the
findings of the National Cancer Peer Review Programme.
Peer Review reports steady improvements in the compli-
ance of the 40 Specialist multidisciplinary teams with the
peer review measures with the median compliance of
85% (range 52-97%) for all measures in the reviews of
2011/12 [21]. There remain a number of areas where
there are centres not meeting the measures and classified
as serious concerns by the Peer Review Programme. Al-
though the number of surgeons per centre has increased
only 43% are providing a 24/7 on call service. In addition
in those centres with more surgeons there are concerns
that work is being diluted with fewer procedures being
performed by individual surgeons. In some Networks
some procedures are still being performed in local units
which do not comply with the Department of Health’s
Guidance on the Commissioning of Cancer Services. The
number of dedicated dieticians has improved but there
are still some services where dietician support is defi-
cient. There are three specific measures in the National
Cancer Peer Review Programme which are only met in
30% of centres. These are regular review meetings be-
tween the specialist centre and the referring diagnostic
units to ensure referrals were consistent. Secondly, all those
with direct clinical contact with patients should attend an
advanced communication skills training programme. Finally
at least one clinical core member should have completed
training to practice at level 2 for psychological support and
this individual should receive a minimum of one hour
supervision by a more experienced practitioner. These lat-
ter two measures are specifically designed to ensure readily
available skilled support for patients and their families.
These issues require further investigation.
Overall the response rate for the questionnaire was
high, giving weight to the findings. A limitation of the
survey is that data is self-reported introducing the risk
of ‘social desirability bias’. Since questions addressed
facts and responses were provided by key informants at
the level of cancer networks and trusts, this bias may be
small in this study. Moreover, our findings resonate well
with the data collected for the National Cancer Peer
Review Programme. Evidently, an assessment of policies
and procedures does not allow direct inference to actual
compliance with practice recommendations at patient
level; however, this will be further assessed by prospect-
ive data collection in the National Oesophago-Gastric
Cancer Audit [22].
Concluding remarks
This survey demonstrates improved compliance with or-
ganisational recommendations over the last five years,
coinciding with the centralisation of services. There is
still room to improve supportive services in management
of these patients, in particular palliative and nutritional
support. Some improvement will need access to greater
resources. But simple measures such as ensuring all pa-
tients are discussed at MDT and that the palliative care
team can attend the MDT may bring about a significant
improvement in patient care.
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